2017 DNAnexus Connect Talks

Featuring world-class speakers presenting cutting-edge research in the field of genomics and beyond.

Clinical Trial Advancement on DNAnexus

Omar Serang

Omar Serang, Chief Cloud Officer at DNAnexus discusses the current state of clinical development, how the use of next-generation sequencing in clinical trials is on the rise, and how DNAnexus clinical trial data services allow customers to incorporate genomic data seamlessly into their clinical trials.

Scaling a Rapid Precision Medicine Program for Acutely Ill Children

Wendy Benson

Wendy Benson, VP of Strategic Initiatives at Rady Children's Institute for Genomic Medicine discusses how Rady is building an end-to-end clinical whole genome data analysis solution, built on the DNAnexus Platform, for children's hospitals nationally.

Translation of NIH Data in Discovery Commons

Will Salerno

Will Salerno, PhD, Director of Genome Informatics, Human Genome Sequencing Center (HGSC) at Baylor College of Medicine discusses the vision for The Commons (i.e. clean data, flexible methods, interactive tools) and how HGSC is scaling its analysis on the cloud.

Moving from a Reactive to a Proactive Approach to Cancer Care

William Dalton

M2Gen CEO, William Dalton, MD, PhD, discusses how ORIEN (Oncology Research Information Exchange Network) helps accelerate cancer discovery through collaborative learning and partnerships.

Beyond 200,000: Insights from Large-Scale Sequencing in the Cloud

Jeffery Reid

Jeffery Reid, PhD, Executive Director, Head of Genome Informatics at Regeneron discusses the Regeneron Genetics Center's (RGC) integrated approach across genetic trait architectures and phenotypes, the underlying cloud infrastructure that makes the center's collaboration with multiple institutions possible, and key lessons learned form RGC's pioneering genomic sequencing study.

Integrative Informatics at MedImmune

Mathew Woodwark

Mathew Woodwark, PhD, Director of Research Bioinformatics at MedImmune discusses the ability to address complex questions through connecting different data types together.

Pharmaceuticals and Healthcare Futures: Threats and Opportunities

Steve Arlington

Steve Arlington, President of Pistoia Alliance discusses the state of the pharmaceutical industry, past, present, and future.

The Janssen Clinical NGS Platform

Ling-Yang Hao

Ling-Yang Hao, PhD, Principal Scientist, Immunology Biomarker at Janssen Pharmaceutical Companies of Johnson & Johnson discusses how Janssen is developing a new platform for disease therapy which incorporates microbiome data into clinical trials.

DNAnexus logo

Copyright © 2017 DNAnexus. All Rights Reserved